Elanco Animal Health Incorporated $ELAN Shares Bought by Profund Advisors LLC

Profund Advisors LLC grew its position in Elanco Animal Health Incorporated (NYSE:ELAN) by 239.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 76,116 shares of the company’s stock after purchasing an additional 53,697 shares during the quarter. Profund Advisors LLC’s holdings in Elanco Animal Health were worth $1,704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Anchor Investment Management LLC bought a new position in Elanco Animal Health in the 2nd quarter worth $29,000. Integrated Wealth Concepts LLC purchased a new position in shares of Elanco Animal Health in the second quarter valued at about $35,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Elanco Animal Health in the second quarter valued at about $38,000. Root Financial Partners LLC purchased a new position in shares of Elanco Animal Health in the third quarter valued at about $41,000. Finally, Bessemer Group Inc. boosted its stake in shares of Elanco Animal Health by 33.2% in the first quarter. Bessemer Group Inc. now owns 2,105 shares of the company’s stock worth $50,000 after acquiring an additional 525 shares during the period. 97.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ELAN has been the topic of several recent analyst reports. The Goldman Sachs Group began coverage on Elanco Animal Health in a research note on Friday, October 16th. They set a “buy” rating and a $32.00 target price on the stock. UBS Group raised their target price on shares of Elanco Animal Health from $31.00 to $33.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. KeyCorp reiterated an “overweight” rating on shares of Elanco Animal Health in a report on Wednesday, September 30th. Weiss Ratings upgraded shares of Elanco Animal Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Friday, September 4th. Finally, Jefferies Financial Group lowered Elanco Animal Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $31.00 to $24.00 in a research report on Tuesday, October 20th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.33.

Elanco Animal Health Stock Performance

NYSE ELAN opened at $24.03 on Tuesday. The company has a market cap of $12.01 billion, a P/E ratio of -58.62, a P/E/G ratio of 2.01 and a beta of 1.70. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.10 and a current ratio of 2.05. The business’s 50 day moving average price is $23.13 and its 200-day moving average price is $23.82. Elanco Animal Health Incorporated has a fifty-two week low of $19.40 and a fifty-two week high of $27.98.

Elanco Animal Health (NYSE:ELAN) last released its earnings results on Wednesday, August 5th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.07. Elanco Animal Health had a negative net margin of 3.96% and a positive return on equity of 8.13%. The firm had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same quarter last year, the business earned $0.26 EPS. The business’s revenue was up 10.2% on a year-over-year basis. Elanco Animal Health has set its Q3 2026 guidance at 0.190-0.220 EPS and its FY 2026 guidance at 1.100-1.160 EPS. Sell-side analysts predict that Elanco Animal Health Incorporated will post 1.13 earnings per share for the current year.

Insiders Place Their Bets

In other Elanco Animal Health news, insider Timothy J. Bettington sold 4,350 shares of the stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $23.00, for a total transaction of $100,050.00. Following the sale, the insider owned 138,911 shares of the company’s stock, valued at approximately $3,194,953. This trade represents a 3.04% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Harrington acquired 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The shares were bought at an average price of $21.82 per share, with a total value of $109,100.00. Following the completion of the purchase, the director directly owned 131,451 shares in the company, valued at $2,868,260.82. The trade was a 3.95% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have purchased 63,198 shares of company stock worth $1,473,109. 1.14% of the stock is owned by corporate insiders.

Elanco Animal Health Profile

Elanco Animal Health Incorporated is a global animal health company that develops, manufactures and markets products for pets and food-producing animals. Its portfolio is designed to help prevent and treat disease, control parasites and support the health and productivity of animals.

The company’s products include vaccines, parasiticides, antibiotics, nutritional supplements and other prescription and over-the-counter therapies. Its companion animal offerings address conditions such as flea and tick infestations, internal parasites, osteoarthritis and dermatological disorders, while its farm animal products support the health of cattle, poultry, swine and aquaculture species.

Elanco serves customers in markets around the world through relationships with veterinarians, animal owners, livestock producers, retailers and distributors.